Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.88%93.35B | 6.87%362.69B | 4.23%84.96B | -3.22%339.37B | 0.84%85.75B | -10.76%90.45B | -5.59%81.66B | 4.79%81.51B | 16.53%350.67B | 7.45%85.04B |
| Cost of revenue | 8.43%62.45B | 7.81%243.05B | 7.71%57.6B | -2.29%225.44B | -4.07%56.21B | -6.41%61.51B | -3.32%54.24B | 6.32%53.47B | 23.13%230.72B | 18.11%58.6B |
| Gross profit | 12.93%30.9B | 5.02%119.65B | -2.42%27.36B | -5.01%113.93B | 11.72%29.54B | -18.77%28.94B | -9.78%27.42B | 2.00%28.04B | 5.64%119.94B | -10.46%26.44B |
| Operating expense | 17.80%27.44B | 8.03%99.05B | 11.26%23.3B | 11.82%91.69B | 7.25%25.08B | 16.06%23.62B | 12.13%22.06B | 12.61%20.94B | 16.83%82B | 18.30%23.38B |
| Operating profit | -14.96%3.46B | -7.40%20.6B | -42.76%4.07B | -41.38%22.24B | 45.86%4.46B | -65.19%5.32B | -49.98%5.36B | -20.16%7.1B | -12.48%37.95B | -68.67%3.06B |
| Net non-operating interest income (expenses) | 1.94%-152M | 3,942.86%283M | -70.33%-155M | 111.86%7M | 74.43%307M | -212.79%-269M | 181.08%60M | -21.33%-91M | 61.69%-59M | 97.75%176M |
| Non-operating interest income | --199M | 115.10%983M | ---- | 72.45%457M | ---- | ---- | ---- | ---- | 50.57%265M | ---- |
| Non-operating interest expense | 126.45%351M | 55.56%700M | 70.33%155M | 38.89%450M | 68.54%150M | 34.88%116M | 25.68%93M | 21.33%91M | -1.82%324M | 2.30%89M |
| Net investment income | -73.81%121M | -0.42%944M | -1.91%462M | 64.01%948M | 250.00%21M | 65.77%431M | -51.92%25M | 68.21%471M | 366.36%578M | 98.23%-14M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 34.07%2.25B | -6.93%3.7B | 20,887.50%1.68B | 489.17%3.97B | 141.82%1.3B | 1,857.35%2.66B | 0 | 8M | 674M | 538M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -92.86%54M | 78.26%-250M | 4,825.00%756M | -469.77%-1.15B | -107.16%-926M | 30.59%-59M | -292.11%-149M | -101.82%-16M | 113.71%311M | 39.27%-447M |
| Less:Other special charges | 92.86%-54M | -113.47%-127M | -4,825.00%-756M | 403.22%943M | 77.63%794M | -118.82%-16M | 292.11%149M | 101.82%16M | -113.71%-311M | -39.27%447M |
| Less:Write off | ---- | 82.13%377M | ---- | --207M | --132M | --75M | ---- | ---- | --0 | --0 |
| Other non-operating income (expenses) | -89.02%46M | 148.18%546M | 91.32%419M | -9.09%220M | -487.88%-194M | 1,542.86%202M | -105.22%-7M | 41.29%219M | -2.42%242M | -37.50%-33M |
| Income before tax | -20.08%5.78B | -1.61%25.82B | -6.05%7.23B | -33.90%26.24B | 51.52%4.97B | -46.90%8.28B | -50.45%5.29B | -24.10%7.69B | -3.10%39.69B | -60.47%3.28B |
| Income tax | -5.49%2.08B | 0.24%8.49B | -1.56%2.21B | -22.99%8.47B | 455.21%1.97B | -45.33%2.55B | -41.62%1.71B | -26.58%2.24B | -5.08%11B | -84.78%355M |
| Net income | -26.49%3.69B | -2.50%17.32B | -7.89%5.02B | -38.08%17.77B | 2.60%3B | -47.57%5.73B | -53.78%3.58B | -23.04%5.45B | -2.32%28.69B | -50.99%2.93B |
| Net income continuous operations | -26.48%3.69B | -2.49%17.32B | -7.89%5.02B | -38.08%17.77B | 2.56%3B | -47.57%5.73B | -53.80%3.58B | -23.03%5.45B | -2.32%28.69B | -50.98%2.93B |
| Noncontrolling interests | -204.03%-453M | -29.52%1.12B | -130.66%-149M | -78.77%1.59B | -6.27%762M | -105.93%-161M | -76.26%502M | -73.60%486M | -13.00%7.48B | -65.32%813M |
| Net income attributable to the company | -19.83%4.15B | 0.16%16.2B | 4.13%5.17B | -23.72%16.18B | 5.96%2.24B | -28.30%5.89B | -45.35%3.08B | -5.27%4.97B | 2.10%21.21B | -41.73%2.11B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -19.83%4.15B | 0.16%16.2B | 4.13%5.17B | -23.72%16.18B | 5.96%2.24B | -28.30%5.89B | -45.35%3.08B | -5.27%4.97B | 2.10%21.21B | -41.73%2.11B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -19.52%21.31 | 1.08%82.98 | 5.46%26.48 | -23.47%82.09 | 8.05%11.54 | -28.19%29.86 | -45.31%15.58 | -5.28%25.11 | 2.10%107.26 | -41.77%10.68 |
| Diluted earnings per share | -19.52%21.31 | 1.08%82.98 | 5.46%26.48 | -23.47%82.09 | 7.37%11.467 | -28.18%29.86 | -45.35%15.5687 | -5.28%25.11 | 2.10%107.26 | -41.77%10.68 |
| Dividend per share | 0 | 6.90%31 | 0 | -23.68%29 | -23.68%29 | 0 | 0 | 0 | 2.70%38 | 2.70%38 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |